(Q39928681)

15 September 2017

1 reference

title

Persistent Dyskinesia (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

7 February 2023

1 reference

G. E. Crane

1

1 reference

PubMed ID

4577946

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4577946

7 February 2023

language of work or name

English

0 references

publication date

1 April 1973

1 reference

full work available at URL

15 September 2017

11

1 reference

based on heuristic

inferred from page(s)

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000087997

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

British Journal of Psychiatry

7 February 2023

published in

1 reference

15 September 2017

122

1 reference

15 September 2017

395-405

1 reference

15 September 2017

569

1 reference

Retrocollis as an irreversible late complication of neuroleptic medication

15 September 2017

2

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

A Case of Amphetamine-Induced Dyskinesia

7 February 2023

6

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Prevention and Management of Tardive Dyskinesia

7 February 2023

7

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Amantadine Hydrochloride Treatment of Tardive Dyskinesia

7 February 2023

13

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Naturally occurring dyskinesias.

7 February 2023

16

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

High Doses of Trifluperazine and Tardive Dyskinesia

7 February 2023

19

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

7 February 2023

Q64895699

21

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Persistent oral dyskinesia in female mental hospital patients.

7 February 2023

24

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

A Study of Facial Dyskinesia in a Mental Hospital Population

7 February 2023

26

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

7 February 2023

Tardive dyskinesia

27

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Motor disorders induced by neuroleptics: a proposed new classification.

7 February 2023

28

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

The structural and biochemical basis of movement disorders in treatment with neuroleptic drugs and in extrapyramidal diseases

7 February 2023

33

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Severe Bartter Syndrome in Blacks

7 February 2023

37

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

The Significance of Brain Damage in Persistent Oral Dyskinesia

7 February 2023

38

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Neuropathological investigation of 28 brains from patients with dyskinesia

7 February 2023

40

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Dextroamphetamine-Sulfate-Induced Dyskinesias

7 February 2023

43

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication

7 February 2023

44

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Failure of pyridoxine to reduce drug-induced dyskinesias

7 February 2023

46

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Persistence of Extra-pyramidal Disorders and Psychiatric Relapse after Withdrawal of Long-Term Phenothiazine Therapy

7 February 2023

52

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Persistent dystonia in a brain-damaged child after ingestion of phenothiazine

7 February 2023

53

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Persistence of Neurological Symptoms Due to Neuroleptic Drugs

7 February 2023

56

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Persistent tardive dyskinesia.

7 February 2023

61

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature

7 February 2023

63

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Involuntary movements in a sample of chronic mental patients and their relation to the treatment with neuroleptics.

7 February 2023

64

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Dyskinesia and Neuroleptics

7 February 2023

65

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Chorea and Phenothiazines

7 February 2023

66

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Extrapyramidal disorders after prolonged phenothiazine therapy

7 February 2023

67

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia

7 February 2023

71

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital

7 February 2023

74

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Tetrabenazine for extra-pyramidal movement disorders

7 February 2023

75

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Intramuscular long-acting fluphenazine in the treatment of schizophrenia

7 February 2023

76

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

A Swallowing Disorder Denoted in Tardive Dyskinesia Patients

7 February 2023

77

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Choreiform movements as side effects of phenothiazine medication in geriatric patients

7 February 2023

80

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Choreoathetosis as a manifestation of thyrotoxicosis

7 February 2023

83

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Use of pyridoxine in chorea

7 February 2023

87

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Treatment of Persistent Phenothiazine-induced Oral Dyskinesia

7 February 2023

89

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Implications of Amphetamine-Induced Stereotyped Behavior as a Model for Tardive Dyskinesias

7 February 2023

90

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy

7 February 2023

93

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia

7 February 2023

96

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Hysteria and depression: the frequency and significance of hysterical personality features in hospitalized depressed women.

7 February 2023

97

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Phenothiazine-induced dyskinesia in nursing-home patients.

7 February 2023

99

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

Abnormal Movements and Prognosis in Schizophrenia

7 February 2023

101

1 reference

https://api.crossref.org/works/10.1192/BJP.122.4.395

7 February 2023

Identifiers

1 reference

15 September 2017

1 reference

PubMed ID

4577946